Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) — Capital Reinvestment Ratio
Suzhou Fushilai Pharmaceutical Co. Ltd. (301258) has a Capital Reinvestment Ratio of 2.24x as of December 2024, meaning it reinvests 2% of its operating cash flow (CN¥47.07 Million) in capital expenditures (CN¥105.31 Million). See 301258 net asset quality score to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Suzhou Fushilai Pharmaceutical Co. Ltd. Capital Reinvestment Ratio (2019–2024)
This chart tracks Suzhou Fushilai Pharmaceutical Co. Ltd.'s Capital Reinvestment Ratio across 6 annual periods. Check 301258 total capital reinvestment ratio to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. (2019–2024)
Year-by-year Capital Reinvestment Ratio for Suzhou Fushilai Pharmaceutical Co. Ltd. from 2019 to 2024. For live market cap and broader valuation context, see Suzhou Fushilai Pharmaceutical Co. Ltd. market capitalisation.
| Year | Reinvestment Ratio | Operating CF (CNY) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.24x | CN¥47.07 Million | CN¥105.31 Million | ▲ +409.4% |
| 2023 | 0.44x | CN¥94.77 Million | CN¥41.62 Million | ▲ +32.5% |
| 2022 | 0.33x | CN¥151.19 Million | CN¥50.11 Million | ▼ -18.0% |
| 2021 | 0.40x | CN¥199.73 Million | CN¥80.75 Million | ▲ +2.7% |
| 2020 | 0.39x | CN¥166.85 Million | CN¥65.69 Million | ▼ -16.4% |
| 2019 | 0.47x | CN¥150.55 Million | CN¥70.93 Million | — |